A systematic review 1 including 23 studies with a total of 1,131 subjects with abdominal or pelvic infections was abstracted in DARE. The dosing regiments were either 600 mg every 8 hours or 900 mg every 8 hours. The mean weighted cure rate for in abdominal infection was 76% (95% CI 59% to 92%) with the lower dosage, and 91% (95% CI 85% to 96%) with the higher dose. In pelvic infections the mean weighted cure rate was 83% with the lower dose and 89% with the higher dose.
Comment: The quality of evidence is downgraded by study quality (limited information of the studies) and by potential reporting bias (limited search).
Primary/Secondary Keywords